Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review

Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Windtree Therapeutics Inc (Windtree Therapeutics) is a biopharmaceutical company that focuses on developing its drug product candidates for the treatment of pulmonary and cardiovascular diseases. The company’s lead development programs are istaroxime, for treating acute decompensated heart failure (ADHF) and cardiogenic shock; Aerosurf, a lucinactant for inhalation, and lyophilized KL4 surfactant intratracheal suspension, both for treating respiratory distress syndrome (RDS) in premature infants; KL4 surfactant for the treatment of lung injury effected by sever Covid-19 infection; oral SERCA2a activators for chronic heart failure; Eleison Oncology for ADS; CVI-IST2 for oral heart failure and rostafuroxin for treating genetically associated hypertension. The company uses its proprietary technology platform Aerosol Delivery System (ADS) with pulmonary surfactants or in combination with other products to treat pediatric and adult respiratory disorders. The company operates in Taiwan, Milan, Taipei and Italy. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc Key Recent Developments

Aug 13,2020: Windtree Therapeutics reports second quarter 2020 financial results and provides key business updates
Jul 21,2020: Windtree adds to team with appointment of three industry veterans
Jul 20,2020: Windtree appoints John Hamill as Chief Financial Officer
Jul 15,2020: Windtree Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 14,2020: Windtree Therapeutics reports first quarter 2020 financial results and provides key business updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Windtree Therapeutics Inc - Key Facts
Windtree Therapeutics Inc - Key Employees
Windtree Therapeutics Inc - Key Employee Biographies
Windtree Therapeutics Inc - Major Products and Services
Windtree Therapeutics Inc - History
Windtree Therapeutics Inc - Company Statement
Windtree Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Windtree Therapeutics Inc - Business Description
Product Category: Grant revenue
Performance
Product Category: License Revenue with Affiliate
Performance
R&D Overview
Windtree Therapeutics Inc - Corporate Strategy
Windtree Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Windtree Therapeutics Inc - Strengths
Windtree Therapeutics Inc - Weaknesses
Windtree Therapeutics Inc - Opportunities
Windtree Therapeutics Inc - Threats
Windtree Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Windtree Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 13, 2020: Windtree Therapeutics reports second quarter 2020 financial results and provides key business updates
Jul 21, 2020: Windtree adds to team with appointment of three industry veterans
Jul 20, 2020: Windtree appoints John Hamill as Chief Financial Officer
Jul 15, 2020: Windtree Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 14, 2020: Windtree Therapeutics reports first quarter 2020 financial results and provides key business updates
Apr 09, 2020: Windtree Therapeutics enters into a material definitive agreement
Apr 09, 2020: Windtree Therapeutics receives loan under Paycheck Protection Program
Apr 02, 2020: Windtree Therapeutics reports fourth quarter 2019 financial results and provides key business updates
Aug 14, 2019: Windtree Therapeutics reports second quarter 2019 financial results and provides key business updates
May 20, 2019: Windtree Therapeutics reports first quarter 2019 financial results and provides key business updates
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


List Of Tables


Windtree Therapeutics Inc, Key Facts
Windtree Therapeutics Inc, Key Employees
Windtree Therapeutics Inc, Key Employee Biographies
Windtree Therapeutics Inc, Major Products and Services
Windtree Therapeutics Inc, History
Windtree Therapeutics Inc, Other Locations
Windtree Therapeutics Inc, Subsidiaries
Windtree Therapeutics Inc, Key Competitors
Windtree Therapeutics Inc, Ratios based on current share price
Windtree Therapeutics Inc, Annual Ratios
Windtree Therapeutics Inc, Annual Ratios (Cont...1)
Windtree Therapeutics Inc, Interim Ratios
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Windtree Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios


List Of Figures


Windtree Therapeutics Inc, Performance Chart (2015 - 2019)
Windtree Therapeutics Inc, Ratio Charts
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020


Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review

Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review

Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review

Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance ReportAssertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available